FORTISTRYER
2021-07-16
๐๐๐
HK's Hutchmed jumps as EMA accepts drug application for tumor treatment
ๅ ่ดฃๅฃฐๆ๏ผไธ่ฟฐๅ ๅฎนไป ไปฃ่กจๅๅธไบบไธชไบบ่ง็น๏ผไธๆๆๆฌๅนณๅฐ็ไปปไฝๆ่ตๅปบ่ฎฎใ
ๅไบซ่ณ
ๅพฎไฟก
ๅคๅถ้พๆฅ
็ฒพๅฝฉ่ฏ่ฎบ
ๆไปฌ้่ฆไฝ ็็็ฅ็ผ่งๆฅๅกซ่กฅ่ฟ็็ฉบ็ฝ
ๆๅผAPP๏ผๅ่กจ็ๆณ
APPๅ ๆๅผ
ๅ่กจ็ๆณ
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":170630037,"tweetId":"170630037","gmtCreate":1626425077129,"gmtModify":1633926860775,"author":{"id":3553149584675358,"idStr":"3553149584675358","authorId":3553149584675358,"authorIdStr":"3553149584675358","name":"FORTISTRYER","avatar":"https://static.tigerbbs.com/ab36eda6ee73b54496452df68d33cead","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>๐๐๐</p></body></html>","htmlText":"<html><head></head><body><p>๐๐๐</p></body></html>","text":"๐๐๐","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/170630037","repostId":2151570311,"repostType":4,"repost":{"id":"2151570311","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626416350,"share":"https://www.laohu8.com/m/news/2151570311?lang=&edition=full","pubTime":"2021-07-16 14:19","market":"hk","language":"en","title":"HK's Hutchmed jumps as EMA accepts drug application for tumor treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2151570311","media":"Reuters","summary":"** Shares of oncology and immunology drug developer and maker Hutchmed (China) Ltd surge 12.2% to HK","content":"<p>** Shares of oncology and immunology drug developer and maker Hutchmed (China) Ltd surge 12.2% to HK$67.95, on course for the best day since listing on June 30</p>\n<p>** Stock hit the highest since July 2, and on track for second session of gains</p>\n<p>** CK Hutchison backed biopharmaceutical firm says the European Medicines Agency (EMA) has accepted its marketing authorization application for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors</p>\n<p>** Says the EMA's validation confirms that the submission is sufficiently complete and it is ready to commence the formal review process, and the company hopes to soon be able to bring the treatment to patients across the U.S. and Europe</p>\n<p>** The Hong Kong Hang Seng Commerce & Industry Index gains 0.3%, while the healthcare index slips 0.6%</p>\n<p>** The benchmark Hang Seng Index climbs 0.3%</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HK's Hutchmed jumps as EMA accepts drug application for tumor treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHK's Hutchmed jumps as EMA accepts drug application for tumor treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-16 14:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Shares of oncology and immunology drug developer and maker Hutchmed (China) Ltd surge 12.2% to HK$67.95, on course for the best day since listing on June 30</p>\n<p>** Stock hit the highest since July 2, and on track for second session of gains</p>\n<p>** CK Hutchison backed biopharmaceutical firm says the European Medicines Agency (EMA) has accepted its marketing authorization application for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors</p>\n<p>** Says the EMA's validation confirms that the submission is sufficiently complete and it is ready to commence the formal review process, and the company hopes to soon be able to bring the treatment to patients across the U.S. and Europe</p>\n<p>** The Hong Kong Hang Seng Commerce & Industry Index gains 0.3%, while the healthcare index slips 0.6%</p>\n<p>** The benchmark Hang Seng Index climbs 0.3%</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00001":"้ฟๅ","00013":"ๅ้ปๅป่ฏ"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151570311","content_text":"** Shares of oncology and immunology drug developer and maker Hutchmed (China) Ltd surge 12.2% to HK$67.95, on course for the best day since listing on June 30\n** Stock hit the highest since July 2, and on track for second session of gains\n** CK Hutchison backed biopharmaceutical firm says the European Medicines Agency (EMA) has accepted its marketing authorization application for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors\n** Says the EMA's validation confirms that the submission is sufficiently complete and it is ready to commence the formal review process, and the company hopes to soon be able to bring the treatment to patients across the U.S. and Europe\n** The Hong Kong Hang Seng Commerce & Industry Index gains 0.3%, while the healthcare index slips 0.6%\n** The benchmark Hang Seng Index climbs 0.3%","news_type":1},"isVote":1,"tweetType":1,"viewCount":267,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/170630037"}
็ฒพๅฝฉ่ฏ่ฎบ